Single measures of viral load can overestimate how many individuals with HIV infection have viral suppression.
HIV, hepatitis B, and hepatitis C infections are more prevalent among patients with severe mental illness than in the general population.
Point-of-Care Tests for HIV and T pallidum Infections: Utility of Smartphone-Based Electronic Reader
A smartphone-based electronic reader with dual point of care tests were evaluated in the detection of antibodies to T pallidum and HIV.
Rapid HIV testing offered to patients in addition to a clinician consultation increases the testing rate in the emergency department.
Women achieving HIV viral suppression in pregnancy can experience viral load rebound predelivery.
The FDA has approved an expanded indication for Epclusa to include the use of this once-daily single tablet regimen in patients co-infected with chronic hepatitis C virus and HIV.
HIV infection may not contribute to incidence of invasive cervical cancer.
The FDA has granted Priority Review to the New Drug Application for Gilead's investigational single-tablet regimen in the treatment of HIV-1 infection.
The microbiome of the area on the penis located under the foreskin in uncircumcised straight men has been linked to increased risk for contracting HIV.
Patients with HIV undergoing antiretroviral therapy saw significant decreases in bone mineral density.
Several technological advances have been developed to improve adherence to antiretroviral and preexposure prophylaxis therapy.
Dr Sara Gianella Weibel talks with Anthony B, a patient with HIV and end-stage amyotrophic lateral sclerosis and the first participant enrolled in the "Last Gift" end-of-life study, about his experience as part of this new end-of-life model to study HIV persistence.
Dr Sara Gianella Weibel talks with Dr Davey Smith, head of the Division of Infectious Disease at the University of California, San Diego, about a proposed new model to study HIV persistence, called the Last Gift study.
Dr Sara Gianella talks with Brooke Sullivan, a transgender woman and HIV activist, about ways to improve transgender individuals' involvement in HIV research.
Dr Sara Gianella talks with Dr Sheldon Morris, from the University of California San Diego AntiViral Research Center about an upcoming PrEP study in transgender people, including understanding HIV prevention in this population, uptake of PrEP, and adherence to treatment.
Persons living with HIV infection have a higher risk for cardiovascular disease; use of some antiretroviral agents can exacerbate this risk.
Critics of the FDA's current restriction on blood donation from MSM argue that it is unnecessary and discriminatory, and propose a policy based on individual risk rather than sexual orientation.
Drs Gianella and Karris discuss the many factors that play a role in the underrepresentation of women in HIV research.
A review of coronary heart disease in patients with HIV.
While 86% of all persons living with HIV in the US know that they are HIV-infected, only an estimated 35% actually achieve viral suppression.
SIGN UP FOR FREE E-NEWSLETTERS
Infectious Disease Advisor Articles
- Guideline Update: Influenza Immunization Recommendations for 2017-2018
- Update on Pediatric HCV: Screening, Treatment, and Other Considerations
- Time to Sputum Culture Conversion Similar in Isoniazid-Resistant and Susceptible TB
- HPV Vaccine Does Not Increase Risk for Adverse Maternal, Infant Outcomes
- DAAs Effective for HCV in Patients With Thalassemia
- Mycoplasma genitalium: Challenges in Diagnosis and Treatment
- FDA: Vabomere Approved for Complicated UTI Following Priority Review
- Update on Safe, Effective Treatments for Latent Tuberculosis Infection
- New CDC Guidelines for SSI Prevention Leave Unanswered Questions
- Influenza Vaccination During Pregnancy Reduces Infant Risk for Acute Lower Respiratory Infection